NuStar GP Holdings, LLC (NSH) Given Consensus Recommendation of “Hold” by Analysts
Shares of NuStar GP Holdings, LLC (NYSE:NSH) have received a consensus rating of “Hold” from the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $22.00.
A number of equities analysts have commented on NSH shares. Citigroup raised shares of NuStar GP from a “neutral” rating to a “buy” rating and set a $17.00 price objective for the company in a report on Tuesday, December 5th. ValuEngine downgraded shares of NuStar GP from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Zacks Investment Research raised shares of NuStar GP from a “hold” rating to a “buy” rating and set a $14.00 price target for the company in a report on Wednesday, February 28th. Finally, B. Riley started coverage on shares of NuStar GP in a report on Friday, January 26th. They set a “buy” rating and a $20.00 price target for the company.
Institutional investors have recently modified their holdings of the business. BNP Paribas Arbitrage SA acquired a new stake in NuStar GP during the 3rd quarter worth about $103,000. Covenant Multifamily Offices LLC acquired a new stake in NuStar GP during the 4th quarter worth about $131,000. Raymond James & Associates acquired a new stake in NuStar GP during the 4th quarter worth about $168,000. Alliancebernstein L.P. raised its holdings in NuStar GP by 5.9% during the 2nd quarter. Alliancebernstein L.P. now owns 8,841 shares of the pipeline company’s stock worth $216,000 after buying an additional 495 shares during the period. Finally, Brown Advisory Inc. grew its stake in NuStar GP by 70.0% during the 4th quarter. Brown Advisory Inc. now owns 17,000 shares of the pipeline company’s stock valued at $267,000 after acquiring an additional 7,000 shares in the last quarter. Hedge funds and other institutional investors own 53.52% of the company’s stock.
NuStar GP (NYSE:NSH) last issued its quarterly earnings results on Thursday, February 8th. The pipeline company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.12). The company had revenue of $10.30 million during the quarter, compared to the consensus estimate of $12.68 million. NuStar GP had a return on equity of 23.82% and a net margin of 168.31%. equities analysts expect that NuStar GP will post 1.42 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Thursday, February 8th were paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 20.19%. The ex-dividend date was Wednesday, February 7th. NuStar GP’s dividend payout ratio is currently 108.46%.
ILLEGAL ACTIVITY WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2018/03/11/nustar-gp-holdings-llc-nsh-given-consensus-recommendation-of-hold-by-analysts.html.
NuStar GP Company Profile
NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.
Receive News & Ratings for NuStar GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP and related companies with MarketBeat.com's FREE daily email newsletter.